Scarica l'app Stockscreener
8.99
2.92%
-0.27
Pre-mercato:
9.01
0.02
+0.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TLRY Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.26
Aprire:
$9.26
Volume 24 ore:
5.10M
Relative Volume:
0.48
Capitalizzazione di mercato:
$1.04B
Reddito:
$829.22M
Utile/perdita netta:
$-248.96M
Rapporto P/E:
-29.97
EPS:
-0.3
Flusso di cassa netto:
$-92.10M
1 W Prestazione:
-0.44%
1M Prestazione:
+22.31%
6M Prestazione:
+78.59%
1 anno Prestazione:
-38.00%
Intervallo 1D:
$8.94
$9.265
Intervallo di 1 settimana:
$8.81
$9.85
Portata 52W:
$3.507
$23.20
Tilray Brands Inc Stock (TLRY) Company Profile
Nome
Tilray Brands Inc
Settore
Telefono
519.322.8800
Indirizzo
655 MADISON AVENUE, NEW YORK
Confronta TLRY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
8.99 | 1.07B | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
125.67 | 57.00B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.90 | 49.88B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.05 | 45.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.40 | 36.84B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
52.88 | 16.33B | 0 | -5.87M | -767.30K | -0.45 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-05 | Reiterato | Alliance Global Partners | Neutral |
| 2022-11-02 | Iniziato | Bernstein | Mkt Perform |
| 2022-07-29 | Downgrade | The Benchmark Company | Hold → Sell |
| 2022-03-04 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-11-18 | Iniziato | Barclays | Underweight |
| 2021-11-01 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-06-11 | Downgrade | CIBC | Sector Outperform → Neutral |
| 2021-06-03 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-05-11 | Ripresa | Cowen | Outperform |
| 2021-05-07 | Ripresa | Jefferies | Buy |
| 2021-05-06 | Iniziato | Canaccord Genuity | Buy |
| 2021-04-28 | Ripresa | BofA Securities | Buy |
| 2021-02-18 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-02-18 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-11-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-11-11 | Downgrade | Stifel | Hold → Sell |
| 2020-10-01 | Reiterato | MKM Partners | Neutral |
| 2020-09-21 | Aggiornamento | Jefferies | Underperform → Hold |
| 2020-05-12 | Reiterato | The Benchmark Company | Buy |
| 2020-04-16 | Downgrade | Jefferies | Hold → Underperform |
| 2020-04-09 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| 2020-02-24 | Downgrade | Cowen | Outperform → Market Perform |
| 2020-01-13 | Iniziato | BofA/Merrill | Neutral |
| 2019-11-13 | Reiterato | The Benchmark Company | Buy |
| 2019-11-05 | Iniziato | Cantor Fitzgerald | Neutral |
| 2019-10-22 | Reiterato | Piper Jaffray | Overweight |
| 2019-09-20 | Iniziato | MKM Partners | Neutral |
| 2019-08-14 | Reiterato | The Benchmark Company | Buy |
| 2019-07-17 | Iniziato | Ladenburg Thalmann | Neutral |
| 2019-06-28 | Iniziato | Consumer Edge Research | Overweight |
| 2019-06-06 | Iniziato | Stifel | Hold |
| 2019-06-05 | Iniziato | Oppenheimer | Perform |
| 2019-05-15 | Aggiornamento | BMO Capital Markets | Underperform → Market Perform |
| 2019-05-13 | Iniziato | Alliance Global Partners | Neutral |
Mostra tutto
Tilray Brands Inc Borsa (TLRY) Ultime notizie
Tilray Brands (NASDAQ:TLRY) Trading Down 2.9%What's Next? - MarketBeat
Cannabis Stocks To Follow NowJanuary 7th - MarketBeat
Tilray Brands (TLRY) $9.49 intraday 06 Jan 2026: Jan 8 earnings may shift outlook - Meyka
Tilray Brands (TLRY) Faces Earnings Headwinds - GuruFocus
Tilray Brands Q2 preview: Bottom line weakness to persist but reclassification offers hope - Seeking Alpha
Tilray Brands, Inc.'s (NASDAQ:TLRY) Shares Bounce 26% But Its Business Still Trails The Industry - 富途牛牛
Top Wall Street analysts adjust their outlook for Tilray Brands prior to Q2 earnings report - Bitget
Top Wall Street Forecasters Revamp Tilray Brands Expectations Ahead Of Q2 EarningsTilray Brands (NASDAQ:TLRY) - Benzinga
What analysts say about Tilray Brands Inc stockEarnings Season Recap & Fast Growing Capital Growth - earlytimes.in
Tilray’s Stock Tests Investor Patience As Cannabis Hype Fades And Diversification Bets Take Center - AD HOC NEWS
Tilray Shares Approach Critical Earnings Report Amid Market Caution - AD HOC NEWS
Tilray Brands Expected to Report Q2 Loss of $0.20 per Share - Intellectia AI
Tilray Brands (NASDAQ:TLRY) Shares Down 2.4%Here's What Happened - MarketBeat
Tilray Brands Inc. Stock Falls Tuesday, Underperforms Market - 富途牛牛
Tilray Q2: Optimism or Tough Truths? - Bitget
Tilray Q2: High Hopes or Harsh Reality?Tilray Brands (NASDAQ:TLRY) - Benzinga
Key facts: Trump calls for cannabis reclassification decision by January; Tilray stock falls 5.65% - TradingView — Track All Markets
Tilray Brands Readies for Q2 Earnings: Here's What You Should Know - Yahoo Finance
Tilray stock forms a risky pattern: Jan. 8 will be key - TradingView — Track All Markets
Tilray Brands Expands Dry January Offerings with Zero-Proof Spirits, Non-Alcoholic Beers and Hemp-Derived THC Beverages - The Manila Times
Tilray Brands Expands Dry January Offerings with Zero-Proof - GlobeNewswire
Tilray Shares Face Heightened Volatility Ahead of Earnings Release - AD HOC NEWS
Promising Cannabis Stocks To Add to Your WatchlistJanuary 3rd - MarketBeat
Top Companies Reporting Earnings This Week: Tilray, Applied Digital, and Others - Bitget
Tilray Shares Brace for Quarterly Earnings Release - AD HOC NEWS
Tilray Brands (NASDAQ:TLRY) Trading Down 2.3%Here's Why - MarketBeat
Top Stocks With Earnings This Week: Tilray, Applied Digital and More - Benzinga
(TLRY) Technical Patterns and Signals (TLRY:CA) - Stock Traders Daily
Best Cannabis Stocks To Add to Your WatchlistJanuary 5th - MarketBeat
Enhance Your Dry January with Mindful Sipping: Try Tilray’s Mollo and XMG Cannabis Beverages - markets.businessinsider.com
Stocks in play: Tilray Brands, Inc. - The Globe and Mail
Is Trump’s Cannabis Rescheduling Order Altering The Investment Case For Tilray Brands (TLRY)? - Yahoo Finance
Tilray (TLRY) Celebrates Dry January with Cannabis Drinks in Can - GuruFocus
Tilray’s Pivotal Earnings Report Approaches Amid Market Uncertainty - AD HOC NEWS
Tilray Brands (2HQ.DE) €0.68 pre-market 05 Jan 2026: Jan 8 earnings in focus - Meyka
Cannabis Stocks To Watch TodayJanuary 4th - MarketBeat
Tilray Shares Gain Momentum Ahead of Critical Quarterly Report - AD HOC NEWS
Top Cannabis Stocks To Watch TodayJanuary 1st - MarketBeat
Tilray Stock Faces Pivotal Test Amid Technical Weakness - AD HOC NEWS
(TLRY) Optimized Trading Opportunities (TLRY:CA) - Stock Traders Daily
Tilray Brands (NASDAQ:TLRY) Trading Up 7.6%Should You Buy? - MarketBeat
Tilray Stock Gains Momentum Amid Regulatory Shift and Upcoming Earnings - AD HOC NEWS
Cannabis Stocks To ResearchJanuary 2nd - MarketBeat
How Long Will the Cannabis Stock Rally Last? - Finviz
How Long Will the Cannabis Stock Rally Last? - The Motley Fool
Best Cannabis Stocks To Watch TodayDecember 29th - MarketBeat
Tilray Shares in Holding Pattern Ahead of Earnings Release - AD HOC NEWS
Short Squeeze: How sustainable is Tilray Brands Inc stock dividend payoutDip Buying & Weekly Return Optimization Alerts - moha.gov.vn
Tilray Shares Struggle to Maintain Momentum Despite Regulatory Shifts - AD HOC NEWS
Tilray Brands Inc: Volatile Cannabis Stock Tests Investors’ Nerves As Wall Street Stays Cautious - AD HOC NEWS
Tilray Brands (TLRY) to Release Earnings on Thursday - MarketBeat
Tilray Brands Inc Azioni (TLRY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Tilray Brands Inc Azioni (TLRY) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
| Persofsky Renah | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
199,726 |
4.03%
2.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):